Take the gains today from ONVO and buy VRNG. VRNG has many more catalysts in the near term. Once you build back your ONVO losses with VRNG then reinvest in ONVO when it's around a buck 4-5 months from now.
Understood Bomba and maybe I appear to cynical but I know from experience that these type of deals are longshots as nothing has been accomplished other than a contract for a development project with some bells and whistles. Immediate revenue from this is less than $200K over the next 2 years in my opinion. More important is the lack of data the company produced at society of toxicology in San Diego 2 weeks ago. The exhibitor hosted session was a disaster as they didn't meet any expectations of data presentation but instead leaded a round-table discussion on the needs for advanced liver models. Basically this screamed that they have nothing ready for prime -time and just a BS marketing exercise. Oh and speaking of marketing you should see the new advertisements they produced for SOT. The most morbid, awful piece of marketing I've ever seen in my 25 years in the life Science industry.
Please!... this deal is based on feasibility of an undeveloped model for L'Oreal's needs. Potentially great news but this is a very long-term development project which needs to pass many hurdles before any serious revenue is captured. 2-3 5 years! This retail horde of investors in ONVO is absolutely nuts in my opinion. cool it and take a back seat until they develop models which are non-exclusive and have some real commercial prowess.